A detailed history of Warwick Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Warwick Investment Management, Inc. holds 1,570 shares of ABT stock, worth $204,147. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,570
Previous 1,674 6.21%
Holding current value
$204,147
Previous $227,000 7.49%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

SELL
$120.51 - $136.62 $12,533 - $14,208
-104 Reduced 6.21%
1,570 $210,000
Q2 2025

Jul 21, 2025

BUY
$123.95 - $138.08 $5,205 - $5,799
42 Added 2.57%
1,674 $227,000
Q1 2025

May 14, 2025

BUY
$111.1 - $140.22 $181,315 - $228,839
1,632 New
1,632 $216,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Warwick Investment Management, Inc. Portfolio

Follow Warwick Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warwick Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Warwick Investment Management, Inc. with notifications on news.